Hao S, Snyder RA, Irish W, et al. - Colon cancer (CC) treatment receipt differed by race even when health insurance coverage was similar, and different racial/ethnic groups faced different disparities. Thus, provision of insurance alone may not eliminate cancer treatment racial disparities.

• A retrospective cohort review of a prospective hospital-based database to examine the link and interaction of race and insurance with CC treatment disparities.

• From the National Cancer Database (2006 to 2016), 353,998 patients with stage I to III CC were included; 73.8% (n = 261,349) were non-Hispanic White (NHW) and 11.7% (n = 41,511) were non-Hispanic Black (NHB).

• Less likelihood of receiving resection [odds ratio (OR) 0.66] or to receive adjuvant chemotherapy [OR 0.83] was observed in NHB patients vs NHW patients.

• The probability of receiving resection and adjuvant chemotherapy was less in NHB patients with private or Medicare insurance, vs similarly insured NHW patients.

• Although there were less chances of undergoing surgical resection in Hispanic patients with private and Medicare insurance, this was not the case with adjuvant chemotherapy.